Plaque

Nurse.org Announces Winners of Annual, Peer-Nominated and Voted ICON Awards

Retrieved on: 
Friday, March 24, 2023
CCRN, Plaque, Community nursing, City College of San Francisco, MSN, Nursing, City college, Boston Red Sox, NICU, ADN, San Francisco State University, ICON, Psychiatric-mental health nurse practitioner, Boston, BSN, APRN, CEN, DNP, Correspondent, Florida International University Alumni Association, PHN, RN, PICU

BELLEVUE, Wash., March 24, 2023 /PRNewswire-PRWeb/ --  Nurse.org, the largest website and community of nurses online, announced the six category winners as well as the ultimate ICON for its annual Nurse ICON Awards. The Nurse.org community nominated and then voted for the winners in six different categories, and also selected Dr. Jonathan V. Llamas, DNP, PMHNP-BC as the ultimate Nurse ICON of the Year.

Key Points: 
  • The Nurse.org community voted Jonathan V. Llamas, DNP, RN-BC, PMHNP-BC, PHN as Nurse Leader of The Year and Nurse ICON of The Year
    BELLEVUE, Wash., March 24, 2023 /PRNewswire-PRWeb/ -- Nurse.org , the largest website and community of nurses online, announced the six category winners as well as the ultimate ICON for its annual Nurse ICON Awards.
  • The Nurse.org community nominated and then voted for the winners in six different categories, and also selected Dr. Jonathan V. Llamas, DNP, PMHNP-BC as the ultimate Nurse ICON of the Year.
  • The Nurse ICON and Nurse Leader of the year, Dr. Jonathan V. Llamas, uses his platform to educate, inspire, and advocate for the importance of mental health care.
  • All winners received a monetary award and plaque, and will be featured on the Nurse.org website, social channels, and award-winning "Ask Nurse Alice" podcast.

6 Steps to Get Better Sleep and Improve Heart Health

Retrieved on: 
Thursday, March 23, 2023
Blood pressure, Plaque, Obesity, Depression, Food, Habit, Diabetes, American Heart Association, Smartphone, Pediatrics, Feinberg School of Medicine, Cholesterol, Overalls, Molina Healthcare, Sleep, Stroke, Cardiovascular disease, Eye, Lipid, Lloyd Jones, Ageing, Vanderbilt University Medical Center, Medicine, Artery, Research, Caffeine, Temperature, Atherosclerosis, Dementia, Computer, Eileen, CDC, Thermoregulation, Documentation, FAHA, Risk, Korea Disease Control and Prevention Agency, Reading, Health, Death, Smoking, Epidemiology, Northwestern University, Northwestern University Dance Marathon, Microsoft family features, Heart Research UK, Herbal cigarette, Pharmaceutical industry, Circadian rhythm

"We know that people who get adequate sleep manage other health factors better as well, such as weight, blood sugar and blood pressure," Lloyd-Jones said.

Key Points: 
  • "We know that people who get adequate sleep manage other health factors better as well, such as weight, blood sugar and blood pressure," Lloyd-Jones said.
  • "The American Heart Association added sleep to the list of factors that support optimal cardiovascular health.
  • Education about healthy heart habits from the American Heart Association is nationally supported by Elevance Health Foundation.
  • Some practices to improve sleep health and impact heart health include:
    Keeping a sleep diary to help track your sleep patterns and habits can make it easier to identify factors that may be helping – or hurting – your sleep quality.

Schneider honors hundreds of drivers for exceptional safe driving milestones

Retrieved on: 
Thursday, March 23, 2023
Trucking, Maritime, Transport, Logistics, Supply Chain Management, Plaque, Haul video, Name, Schneider, NYSE, Safety, Rail transport, Ridesharing, Fame

In a series of banquets across the U.S. the carrier will celebrate Million Mile Driver Awards and Consecutive Safe Driving Awards, each signaling the achievement of milestones in drivers’ careers.

Key Points: 
  • In a series of banquets across the U.S. the carrier will celebrate Million Mile Driver Awards and Consecutive Safe Driving Awards, each signaling the achievement of milestones in drivers’ careers.
  • “Schneider Haul of Fame drivers – and all of our award recipients - reflect our ongoing commitment to safety,” said Schneider President and CEO Mark Rourke.
  • In addition, 120 drivers earned the Consecutive Safe Driving Award for remaining accident-free for milestones ranging from 10 to 30 years.
  • Drivers who accumulated three million safe driving miles and/or 20 consecutive years of safe driving without a preventable accident earn the exclusive honor of being added to Schneider’s Haul of Fame.

China's solution: Community with a shared future for mankind

Retrieved on: 
Thursday, March 23, 2023
DNA, Communication, Poverty, Plaque, People's Liberation Army Navy, Public, African, Flower, Carbon, Nature, Notre Dame, Safety, Management, Renewable energy, Tourism

Rooted in such historical background, Chinese President Xi Jinping initiated the idea of "building a community with a shared future for mankind," which serves as China's solution to the everchanging global landscape complexed by multiple challenges.

Key Points: 
  • Rooted in such historical background, Chinese President Xi Jinping initiated the idea of "building a community with a shared future for mankind," which serves as China's solution to the everchanging global landscape complexed by multiple challenges.
  • "When the world is in chaos, no country would live in peace; when a country is in chaos, every household would suffer."
  • Building a clean and beautiful world is a necessary part in building a community with a shared future for mankind.
  • With the vision of building a community with a shared future for mankind, the coming decade will be more beautiful.

Zesty Paws® Presents Eight New Dog and Cat Supplements at Global Pet Expo

Retrieved on: 
Tuesday, March 21, 2023
Allergen, Heart, Orange County Convention Center, Cellulose, Plaque, Food, Melatonin, Hip, DHA, Milk, Marketing, Dog, Parent, Booth, Immunity, APPA, Psyllium, Cat, Chamomile, Colostrum, Animal, Global Pet Expo, Immune system, Pet, CBD, Ageing, Charitable organization, Relaxation, Probiotic, Antioxidant, Dentistry, Vaccine, Dietary supplement, Petroleum jelly

ORLANDO, Fla., March 21, 2023 /PRNewswire-PRWeb/ -- Zesty Paws®, an award-winning functional pet supplement brand, will be introducing its newest products at this year's Global Pet Expo, including their first oral health product, All-in-One Functional Dental Bones™, as well as All-in-One Training Bites™, two award-winning CBD supplements for cats and a line of puppy products ranging from Milk Replacer to supplements. Expo attendees can visit Zesty Paws at Booth #1609 on March 22-24 at the Orange County Convention Center in Orlando, Florida, to learn more about the brand's latest innovations for dogs and cats.

Key Points: 
  • Expo attendees can visit Zesty Paws at Booth #1609 on March 22-24 at the Orange County Convention Center in Orlando, Florida, to learn more about the brand's latest innovations for dogs and cats.
  • "We can't wait to share some of our breakthrough product innovations at Global Pet Expo as Zesty Paws expanded into three new categories for dogs and cats," said vice president of marketing for Zesty Paws Yvethe Tyszka.
  • Zesty Paws will have eight new products on display at Global Pet Expo:
    Zesty Paws® All-In-One Functional Dental Bones ™ are made with wholesome ingredients like sweet potato flour, turmeric and cinnamon, as well as EpiCor® Pets.
  • In addition to the pledge of a monetary donation to the APPA's partners, Zesty Paws will also donate all products from the show to the Pet Alliance, a longtime partner of Zesty Paws.

Wheaton Bekins Names Drivers of the Year

Retrieved on: 
Thursday, March 9, 2023
Wheaton, Freedom, Record, Dog, Paluch, Bailey, Month, Safety, United Van Lines, Chicago White Sox, Plaque, Food delivery, Video game

Four drivers among the best in the moving industry

Key Points: 
  • Bailey earned his second Wheaton | Bekins Driver of the Month award in July 2022 and his first Driver of the Year award in 2022.
  • Basham earned his fourth Wheaton | Bekins Driver of the Month award in January 2022 and first Driver of the Year award in 2022.
  • Winne earned his first Wheaton | Bekins Driver of the Month award in July 2022 and first Driver of the Year award in 2022.
  • Each winning driver receives a Driver of the Year plaque from Wheaton | Bekins, along with a $2,000 cash award.

How is Novozymes OneHealth leading the probiotic market segment in FIC2023?

Retrieved on: 
Thursday, March 16, 2023
Jiangnan University, Probiotic, Research, Health, Emotion, Food microbiology, Attitude, Sleep, Life, Overalls, Partnership, Human, Biotechnology, IBS, Exhibition, Food industry, Novozymes, Sanofi, Growth, Philosophy, Marketing, Genetically modified food, Drug resistance, FIC, Plaque, R, Dietary supplement, WonderLab

Novozymes OneHealth participated in the exhibition with the theme of “Exploration and Discovery” and discuss the future trend of food industry!

Key Points: 
  • Novozymes OneHealth participated in the exhibition with the theme of “Exploration and Discovery” and discuss the future trend of food industry!
  • OneHealth has always been committed to thorough insights into consumer pain points and needs in order to bring targeted solutions to the market and continue to lead the probiotic market segment.
  • OneHealth is precisely rooted in the market and has established partnerships with many well-known brands.
  • While focusing on achievements, it is worthwhile for the OneHealth strategy team and the entire probiotic industry to think about how to bring the OneHealth brand and products deeper into the market and do a better job in the probiotic segment.

U.S. Veterans' Health Administration (VHA) Provides Coverage of LEQEMBI (lecanemab-Irmb) Two Months After LEQEMBI's FDA Accelerated Approval for Veterans Living with Early Stages of Alzheimer's Disease

Retrieved on: 
Tuesday, March 14, 2023
The New England Journal of Medicine, Tradition, Brain, Veteran, Pathology, Co-promotion, Priority review, VHA, Lecanemab, Patient, Clarity, FDA, Clinical trial, PDUFA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, AD, Plaque, Immunoglobulin G, Pharmaceutical industry, Alzheimer's disease, Biogen, Disease, Eisai

The VHA's careful consideration and timely action to make LEQEMBI available approximately two months after the FDA approved LEQEMBI under the accelerated approval pathway shows its continued commitment to veterans living with AD.

Key Points: 
  • The VHA's careful consideration and timely action to make LEQEMBI available approximately two months after the FDA approved LEQEMBI under the accelerated approval pathway shows its continued commitment to veterans living with AD.
  • If approved under the traditional pathway, the FDA will update the label for LEQEMBI, which will include new data that has been evaluated by the FDA.
  • The FDA has determined that the results of Clarity AD will serve as the confirmatory study to verify the clinical benefit of LEQEMBI.
  • On the same day that LEQEMBI received its Accelerated approval, Eisai submitted the supplemental Biologics License Application (sBLA) to the FDA for approval under the Traditional pathway.

FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease

Retrieved on: 
Monday, March 6, 2023
The New England Journal of Medicine, Brain, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Co-promotion, Pathology, Priority review, BIIB, Lecanemab, Patient, Clarity, FDA, Clinical trial, Oncology Drug Advisory Committee, PDUFA, Prescription Drug User Fee Act, Food, Advisory Committee, AD, Plaque, Immunoglobulin G, Pharmaceutical industry, Medical imaging, Alzheimer's disease, Biogen, Eisai

The LEQEMBI application has been granted Priority Review, with a Prescription Drug User Fee Act (PDUFA) action date of July 6, 2023.

Key Points: 
  • The LEQEMBI application has been granted Priority Review, with a Prescription Drug User Fee Act (PDUFA) action date of July 6, 2023.
  • The FDA is currently planning to hold an Advisory Committee to discuss this application but has not yet publicly announced the date of the meeting.
  • On the same day that LEQEMBI received its accelerated approval, Eisai submitted the sBLA to the FDA for approval under the traditional pathway.
  • The sBLA is based on the findings from Eisai's recently published large, global confirmatory Phase 3 clinical trial, Clarity AD.

Roivant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old

Retrieved on: 
Wednesday, March 15, 2023
Linda, 2020 Henry Ford Health System 200, Adolescence, Pediatrics, Quality of life, Atopic dermatitis, Itch, Psoriasis, BSA, Clinical research, Dermatitis, Body surface area, Roivant Sciences, Patient, Rady, Physician, FDA, Pharmacist, Diagnosis, Prescription, JD, Week, Plaque, Surveying, Pharmaceutical industry, Cosmetics, Dietary supplement, EASI, MD, Dermatology

“Atopic dermatitis, the most common type of eczema, affects more than 9.6 million children and 16.5 million adults in the United States.

Key Points: 
  • “Atopic dermatitis, the most common type of eczema, affects more than 9.6 million children and 16.5 million adults in the United States.
  • In the U.S., VTAMA cream is already approved for the topical treatment of plaque psoriasis in adults.
  • Importantly, VTAMA cream data indicated no safety or tolerability signals in this population including children as young as 2 years old.
  • “Atopic dermatitis can have a negative impact on the quality of life of diagnosed children as well as their families.